Autosomal Dominant Polycystic Kidney Patients May Be Predisposed to Various Cardiomyopathies

por Chebib, Fouad T., Hogan, Marie C., El-Zoghby, Ziad M., Irazabal, Maria V., Senum, Sarah R., Heyer, Christina M., Madsen, Charles D., Cornec-Le Gall, Emilie, Behfar, Atta, Harris, Peter C., Torres, Vicente E.
Publicado 2017

Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial

por Cornec-Le Gall, Emilie, Blais, Jaime D, Irazabal, Maria V, Devuyst, Olivier, Gansevoort, Ron T, Perrone, Ron D, Chapman, Arlene B, Czerwiec, Frank S, Ouyang, John, Heyer, Christina M, Senum, Sarah R, Le Meur, Yannick, Torres, Vicente E, Harris, Peter C
Publicado 2018

Evidence of a third ADPKD locus is not supported by reanalysis of designated PKD3 families

por Paul, Binu M., Consugar, Mark B., Lee, Moonnoh Ryan, Sundsbak, Jamie L., Heyer, Christina M., Rossetti, Sandro, Kubly, Vickie J., Hopp, Katharina, Torres, Vicente E., Coto, Eliecer, Clementi, Maurizio, Bogdanova, Nadja, de Almeida, Edgar, Bichet, Daniel G., Harris, Peter C.
Publicado 2013

Strategy and rationale for urine collection protocols employed in the NEPTUNE study

por Hogan, Marie C., Lieske, John C., Lienczewski, Chrysta C., Nesbitt, Lisa L., Wickman, Larysa T., Heyer, Christina M., Harris, Peter C., Ward, Christopher J., Sundsbak, Jamie L., Manganelli, Luca, Ju, Wenjun, Kopp, Jeffrey B., Nelson, Peter J., Adler, Sharon G., Reich, Heather N., Holzmann, Lawrence B., Kretzler, Matthias, Bitzer, Markus
Publicado 2015